	Nutrient requirements for adults with ulcerative colitis over the disease course: a systematic scoping review. Crit Rev Food Sci Nutr Plush S, Bryant RV, Davis RH, Kumar S, Day AS. PMID: 41649484 [PubMed - as supplied by publisher]
	The interplay mechanisms between gut microbiota and ferroptosis in inflammatory bowel disease. Front Immunol Shi Z, Zhang S, Zhai H, Wu Q, Li Y, Xu H, Zhang S. PMID: 41646847 [PubMed - indexed for MEDLINE]
	A Multi-Mineral Intervention Improves Intestinal Permeability in Patients with Ulcerative Colitis: Results from a 90-Day Pilot Trial. medRxiv Aslam MN, Turgeon DK, McClintock S, Allen R, Sen A, Varani J. PMID: 41646788 [PubMed]
	Redrawing the gut map: evolving probiotic approaches to microbiota modulation in inflammatory bowel disease. Antonie Van Leeuwenhoek Vaghela P, Dave B, Dabhade A, Deshmukh R, Prajapati B, Alsaidan OA, Patel S, Mehta A, Singh A, Dudhat K. PMID: 41644858 [PubMed - indexed for MEDLINE]
	Optimizing vedolizumab therapy in ulcerative colitis: A critical synthesis of trial evidence and the emerging role of artificial intelligence. PLOS Digit Health Abdulfattah A. PMID: 41642870 [PubMed]
	Latent tuberculosis screening for inflammatory bowel disease in tuberculosis endemic region remains porous and suboptimal: A multicentre study. World J Gastroenterol Jha DK, Prasad S, Valsan A, Mishra S, Nair P, Koshy AK, Singh S, Prasad AS, Shukla R, Ahamed R, Augustine P, Natarajan K, Peddi K, Kulkarni A, Bhatia S, Pachisia AV, Singh PK, Jena A, Gupta S, Jain S, Padmaprakash K, Kakadiya R, Kumar A, Shukla S, Dutta U, Hande V, Thareja S, Sharma V. PMID: 41640875 [PubMed - indexed for MEDLINE]
	Antibiotic consumption of inpatients with inflammatory bowel disease during 2015-2024 and future prediction: Evidence from a general hospital. World J Gastroenterol Zeng W, Zhang WK, Xu D, He K, Huang YP, Liu YX, Yang HF. PMID: 41640873 [PubMed - indexed for MEDLINE]
	Characteristics of gut microbiota and metabolites in patients with ulcerative colitis with fatigue. World J Gastroenterol Liu ZX, Liu XY, Tan WW, Zhang WB, Zhang YL, Zheng L, Dai YC. PMID: 41640612 [PubMed - indexed for MEDLINE]
	Role of leucine-rich Î±-2-glycoprotein in Taiwanese patients with inflammatory bowel disease as a predictive biomarker for endoscopic activity. World J Gastroenterol Chen YC, Weng MT, Tsai FP, Chen ZC, Wu HY, Tung CC, Wang CY, Wei SC. PMID: 41640607 [PubMed - indexed for MEDLINE]
	Investigation of Blastocystis spp. in patients with inflammatory bowel disease by direct microscopy and molecular methods. Afr Health Sci Feride , Rug, Hüseyin K, Salih M. PMID: 41640525 [PubMed - indexed for MEDLINE]
	AAV9-Delivered Î±7nAChR Ameliorates DSS-Induced Murine Ulcerative Colitis by Activating CAP Pathway, Inhibiting NF-ÎºB/NLRP3 Axis and Restoring Intestinal Barrier and T-reg/Th-17 Homeostasis. Drug Dev Res Zhang R, Yang Q, Bi H. PMID: 41637679 [PubMed - indexed for MEDLINE]
	Continuing Medical Education Questions: January 2026. Am J Gastroenterol Moutsoglou D. PMID: 41637094 [PubMed - indexed for MEDLINE]
	Comparative efficacy and safety of mesalazine-based regimens with traditional Chinese medicines in mild-to-moderate ulcerative colitis. Front Pharmacol Huang B, An H, Chen L, Lin H, Wu H, Li R, Su Y, Lin J, Shi D. PMID: 41635924 [PubMed]
	Increase in serum prolactin levels as a potential biomarker in Crohn's disease: a prospective cohort study. Front Med (Lausanne) Lu M, Xu M, Tang X, Qiao L, Chen H, Yang B. PMID: 41635471 [PubMed]
	Association of tissue lymphocyte immunophenotype and clinical outcomes: A prospective study in patients with ulcerative colitis treated with vedolizumab. PLoS One Ando K, Kashima S, Sakatani A, Konishi H, Maemoto A, Ito T, Taruishi M, Hamagami K, Ishiguro K, Fujiya M. PMID: 41632771 [PubMed - indexed for MEDLINE]
	Etrasimod: A Next-Generation S1P Receptor Modulator for Ulcerative Colitis - Mechanistic Insights and Clinical Progress. Zhongguo Ying Yong Sheng Li Xue Za Zhi Kumbhare MR, Shaikh AS, Ide BR, Gode HS, Pagere ND, Porje RK. PMID: 41630551 [PubMed - indexed for MEDLINE]
	Efficacy of mirikizumab induction therapy in inflammatory bowel disease: A systematic review and meta-analysis. Medicine (Baltimore) Khan SA, Marasini A, Khanam B, Shrestha A, Khan S, Kausar H, Kauser H, Parajuli SB, Khan E. PMID: 41630334 [PubMed - indexed for MEDLINE]
	Long-term outcomes of Kono-S anastomosis for ileocecal resections in Crohn's disease: a comparative analysis. Int J Colorectal Dis Vojta M, Hermann M, Kienle P, Reißfelder C, Weiß C, Hardt J, Seyfried S. PMID: 41629511 [PubMed - indexed for MEDLINE]
	Tolerability and impact on postoperative morbidity of preoperative bowel preparation in Crohn's disease patients: results of prospective observational study. Int J Colorectal Dis Igors I, Aline S, Nils H, Dominika I, Zdenek K, Tomas G, Lumir K. PMID: 41627485 [PubMed - indexed for MEDLINE]
	Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-NaÃ¯ve Ulcerative Colitis with Severe Endoscopic Disease. Am J Gastroenterol Wong ECL, Jairath V, Dulai PS, Marshall JK, Ma C, Reinisch W, Narula N. PMID: 41626838 [PubMed - as supplied by publisher]

Articles 1 - 20 / 56660

Page 1 of 2833



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy